You have 9 free searches left this month | for more free features.

Overall Status

Active, not recruiting (1)

Enrolling by invitation (1)

Recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

Salarius Pharmaceuticals, LLC (2)

M.D. Anderson Cancer Center (1)

Collaborator

National Pediatric Cancer Foundation (1)

Intervention

seclidemstat (3)

azacitidine (1)

cyclophosphamide (1)

topotecan (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (2)

Other (1)

Study Type

Interventional (3)

seclidemstat

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Chronic Myelomonocytic Leukemia-0, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Houston

Active, not recruiting

Chronic Myelomonocytic Leukemia-0
+5 more

Azacitidine
Seclidemstat

Houston, Texas

M D Anderson Cancer Center

Jan 18, 2023

Ewing Sarcoma, Myxoid Liposarcoma, Desmoplastic Small Round Cell Tumor Trial in Santa Monica (Seclidemstat)

Enrolling by invitation

Ewing Sarcoma
+8 more

Seclidemstat

Santa Monica, California

Sarcoma Oncology Center

Feb 23, 2022

Ewing Sarcoma, Myxoid Liposarcoma, Sarcoma,Soft Tissue Trial in United States (Seclidemstat, Cyclophosphamide, Topotecan)

Recruiting

Ewing Sarcoma
+10 more

Seclidemstat
+2 more

Los Angeles, California
+16 more

Jan 18, 2022